BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 2927045)

  • 1. Update: universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health-care settings.
    Kans Nurse; 1989 Jan; 64(1):2-3. PubMed ID: 2927045
    [No Abstract]   [Full Text] [Related]  

  • 2. Update: universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health-care settings.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1988 Jun; 37(24):377-82, 387-8. PubMed ID: 2836717
    [No Abstract]   [Full Text] [Related]  

  • 3. Update: universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health-care settings.
    N Y State J Med; 1988 Dec; 88(12):649-51. PubMed ID: 3231391
    [No Abstract]   [Full Text] [Related]  

  • 4. Universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health-care settings.
    Can Dis Wkly Rep; 1988 Jul; 14(27):117-24. PubMed ID: 3242885
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of occupational transmission of bloodborne diseases in clinical nurse anesthesia practice.
    Griffis CA
    CRNA; 2000 Feb; 11(1):2-7. PubMed ID: 11271034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Universal precautions for preventing transmission of bloodborne pathogens in health care facilities: report of a consensus committee meeting.
    CMAJ; 1989 Apr; 140(7):824-6. PubMed ID: 2647257
    [No Abstract]   [Full Text] [Related]  

  • 7. Universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health-care settings.
    AORN J; 1988 Sep; 48(3):586-8, 590-2, 594-6. PubMed ID: 3178201
    [No Abstract]   [Full Text] [Related]  

  • 8. Leads from the MMWR. Update: universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health-care settings.
    JAMA; 1988 Jul 22-29; 260(4):462-5. PubMed ID: 2838652
    [No Abstract]   [Full Text] [Related]  

  • 9. Bloodborne pathogens and OSHA standards.
    Gilman JW
    Kans Nurse; 1992 May; 67(5):1-2. PubMed ID: 1318437
    [No Abstract]   [Full Text] [Related]  

  • 10. The bloodborne pathogens final rule. Understanding the regulation.
    Bruning LM
    AORN J; 1993 Feb; 57(2):439-51, 454-66. PubMed ID: 8424632
    [No Abstract]   [Full Text] [Related]  

  • 11. [Protection of hospital personnel against risks of exposure to blood].
    Bouvet E; Tarantola A
    Rev Prat; 1998 Sep; 48(14):1558-62. PubMed ID: 9814052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infection control standards for health care workers.
    Koster M
    Qld Nurse; 1990; 9(4):6-9. PubMed ID: 2122493
    [No Abstract]   [Full Text] [Related]  

  • 13. The new OSHA regulations on occupational exposure to bloodborne pathogens.
    Howard-Martin J
    Healthspan; 1992 Feb; 9(2):18-24. PubMed ID: 10117859
    [No Abstract]   [Full Text] [Related]  

  • 14. Preventing the transmission of bloodborne pathogens in health care and public service settings.
    Can Commun Dis Rep; 1997 May; 23 Suppl 3():i-vii, 1-43, i-vii, 1-52. PubMed ID: 11195251
    [No Abstract]   [Full Text] [Related]  

  • 15. The OSHA bloodborne pathogens standard.
    Jackson MM; Pugliese G
    Todays OR Nurse; 1992 Jul; 14(7):11-6. PubMed ID: 1636201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occupational exposure to bloodborne pathogens--OSHA. Final rule.
    Fed Regist; 1991 Dec; 56(235):64004-182. PubMed ID: 10115865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidelines for health care workers who have hepatitis B virus or human immunodeficiency virus infection.
    Thomas MG
    N Z Med J; 1992 Mar; 105(929):86-7. PubMed ID: 1545945
    [No Abstract]   [Full Text] [Related]  

  • 18. Recommendations for preventing transmission of infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in the workplace.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Nov; 34(45):681-6, 691-5. PubMed ID: 2997587
    [No Abstract]   [Full Text] [Related]  

  • 19. Universal precautions. Report of a Consensus Committee Meeting.
    Can Dis Wkly Rep; 1989 Feb; 15(5):23-8. PubMed ID: 2924361
    [No Abstract]   [Full Text] [Related]  

  • 20. Report of the Committee on Infectious Diseases.
    J Clin Neurophysiol; 1994 Jan; 11(1):128-32. PubMed ID: 8195418
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.